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Abstract 
For the cell type diagnosis of leukemia in adult pa-
tients, particularly when the sampling of bone marrow 
is difficult, the study of peripheral blood leukocytes 
(PBLs) by immuno-electron microscopy provides signifi-
cant information, as illustrated here in two cases of hairy 
cell leukemia and seven cases tentatively identified as 
megakaryoblastic leukemia (M7). Indirect immunogold 
labeling with the B-ly7 monoclonal antibody (CD103) 
proved valuable in confirming the diagnosis of hairy cell 
leukemia. Immunogold labeling for the GplIIa platelet 
glycoprotein (CD61) was used in cases where the light 
microscopy of blood films revealed possible megakaryo-
blastic leukemia. Under the electron microscope, how-
ever, the CD61 positive cells showed, in almost all 
cases, a wide spectrum of megakaryopoietic differentia-
tion which made the diagnosis of M7 questionable. 
Most of the CD61 positive cells featured cytoplasmic 
differentiation markers such as alpha granules and de-
marcation membranes, further confirming the presence 
of circulating megakaryocythemia, a phenomenon de-
scribed many years ago in various myeloproliferative 
disorders . It is suggested, therefore, that many of these 
cases should not be identified as true megakaryoblastic 
leukemias. 
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Introduction 
In adult patients, leukemias are classified in distinct 
subtypes which are routinely diagnosed by examination, 
under the light microscope, of bone marrow aspirates or 
biopsies, and of peripheral blood films. The F AB clas-
sification (Bennett et al., 1976, 1985) recognizes seven 
myeloid (Ml to M7) and three lymphoblastic (Ll, L2 
and L3) forms of the disease. 
Thirty years ago, recognizing the various leukemic 
subtypes was of questionable redeeming value since 
prognosis was invariably fatal. Although precise cell 
typing has sometimes been regarded as an academic 
exercise, it provides important prognostic information, 
since myeloid leukemias follow a more aggressive 
course than lymphoblastic disease. 
Fortunately, the prognosis of acute leukemias has 
been significantly improved over the past decades by : 
(1) the progress of chemotherapy, and (2) the refinement 
of methods for bone marrow transplantation. However, 
the most encouraging results of several therapeutic pro-
tocols are, as reported worldwide, cell-type restricted. 
For example, alpha-interferon, deoxycoformycin and 
2-chlorodeoxyadenosine induce very prolonged remis-
sions in almost ail cases of hairy cell leukemia (HCL), 
while the same treatments are apparently of no therapeu-
tic value in other forms of leukemia. In promyelocytic 
leukemia (PML, FAB: M3) , all-trans retinoic acid alone 
results in significant remissions, while the same therapy 
has no effect in other types of leukemias. Obviously, 
precise cell typing of acute leukemias is no longer an 
academic exercise. It has become an absolute necessity 
for the selection of the most appropriate therapy for each 
individual case of leukemia. 
Precise cell typing can be achieved by several 
methods: (1) routine hematology, (2) flow cytometry, 
(3) cytogenetics, (4) molecular diagnosis, and (5) ultra-
structural characterization of the leukemic cells by elec-
tron microscopy. A combination of these methods is 
probably the most efficient approach to correct diagno-
sis, in spite of their relatively poor concordance reported 
recently (Choi et al., 1994). 
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Figure 1. Two typical hairy cells featuring the characteristic broad based surface projections and several short 
microvilli. Their cytoplasm is moderately rich in organelle (mitochondria and rough ER). Nuclei have some margina-
tion of heterochromatin and inconspicuous nucleoli . 
The purpose of this paper is to demonstrate that 
transmission and scanning immuno-electron microscopy 
of peripheral blood leukocytes (PBLs) of leukemic pa-
tients provide valuable diagnostic information not readily 
obtainable by other methods, particularly when bone 
marrow aspiration is difficult or non-diagnostic. This is 
frequently the case in hairy cell leukemias (HCL) and in 
megakaryoblastic leukemias (M7) with myelofibrosis 
(Bennett et al., 1985). The use of immuno-electron mi-
croscopy in the study of hairy cell and of megakaryo-
blastic leukemia is particularly indicated in view of the 
absence of cytogenetic markers and the inaccuracy of 
flow cytometry for the study of these two diseases. In-
deed, flow cytometry can hardly distinguish between 
megakaryocyte precursors, giant platelets, and platelet 
aggregates. 
Materials and Methods 
Peripheral blood leukocytes 
A close collaboration with the Hematology/Oncolo-
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gy clinic at the Toronto General Hospital allowed us to 
select cases in which a diagnosis of hairy cell leukemia 
(HCL) or of megakaryoblastic leukemia (M7) was sus-
pected by light microscopy of blood films. 
Citrated peripheral blood was collected from these 
patients prior to initiation of chemotherapy. Mononucle-
ar cells were separated by centrifugation on Ficoll-
Hypaque gradients, and prefixed for 10 minutes (not any 
longer!) with a solution of phosphate buffered 0.1 % 
glutaraldehyde which will prevent internali?.ation of the 
antigen-antibody-gold complexes. All preparatory steps 
were at room temperature. When a diagnosis of HCL 
was anticipated (2 cases), the mononuclear cells were 
incubated for 60 minutes with an undiluted preparation 
(110 µg/ml) of the B-ly7 murine monoclonal antibody 
(Poppema et al., 1989; Visser et al. , 1989; de Harven 
et al., 1994). When a diagnosis of megakaryoblastic 
leukemia was suspected (7 cases), the cells were incu-
bated with a 1:50 dilution of the anti-GpIIIa (CD61) 
murine monoclonal antibody (Y2/51, Dakopatts, 
Glostrup, Denmark). For scanning electron microscopy 
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Figure 2. Indirect immunogold labeling of another hairy cell incubated with the B-ly7 antibody and studied at high 
magnification to facilitate the observation of the numerous 5 nm gold markers, frequently seen in small clusters on cell 
surface (arrows). 
(SEM), cells were attached on poly-I-lysine coated glass 
coverslips and dip-rinsed for all preparatory steps, 
strictly avoiding any risk of air drying. For trans-
mission electron microscopy (TEM), the cells were incu-
bated in suspension and centrifuged at low speed for 
each step. Since indirect immunogold labeling was 
used, secondary incubation was with goat anti-murine 
IgG 1 adsorbed on 5 nm colloidal gold particles for TEM 
and 30 nm colloidal gold particles for SEM (GAM-G5 
and GAM-G30, respectively, from Janssen Pharmaceu-
tica, Beerse, Belgium). Dilution of the antibody con-
jugates depended on gold particle size: 1:20 for the 5 
nm, and 1: 10 for the 30 nm size particles. Final fixa-
tion was with 2.5 % glutaraldehyde followed by osmium 
tetroxide for TEM, and with glutaraldehyde alone for 
SEM. Fragments of cell pellet were embedded in Epon/ 
Araldite for TEM; SEM coverslips were dried at the 
critical point of CO2 and conductive coated with evapo-
rated carbon only. For TEM, a JEOL 1200-EXII 
(JEOL-USA, Inc., Peabody, Mass.) was used, at origi-
nal magnification ranging from 4,000 to 25,000 X. For 
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SEM, a JEOL 840 instrument was used, fitted with the 
standard solid state annular backscattered electron 
detector and with a lanthanum hexaboride cathode 
(Denka, Mitsui and Co. , Tokyo, Japan). Imaging was 
at 15 kV accelerating voltage for both secondary (SE) 
and backscattered electron (BE) signals. 
More details on the procedures used for immuno-
gold labeling have been previously published (de Harven 
and Soligo, 1986, 1989; de Harven et al., 1984). 
Results 
Hairy cell leukemias 
Under the TEM, hairy cells are primarily identified 
by their long, "dagger-shaped" surface projections. 
These projections are, in most cells, easily distinguished 
from surface microvilli by their greater length and by 
their diameter which is characteristically larger near the 
cell surface than at the tip of the projection. In nearly 
50% of the cases (Daniel and Flandrin, 1974), the 
cytoplasm features a very distinct structure classically 
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Figure 3. Scanning electron micrograph of the hairy cells illustrating the typical ruffling surface morphology. The 
gold markers are only faintly recognized in this secondary electron image. 
described as "ribosome-lamellae complex" or RLC 
(Katayama et al., 1972). The presence of these struc-
tures strongly supports a diagnosis of HCL, although 
their absence does not rule it out. Moreover, it should 
be emphasized that RLC have been described in non-
hairy cell diseases. RLC were observed in only one of 
the two cases studied here. Other cytoplasmic organel-
les (mitochondria, Golgi, RER) were unremarkable, al-
though their large number suggested well differentiated 
cells, not primitive blasts. With a significant amount of 
marginated heterochromatin and small, inconspicuous 
nucleoli (Fig. 1), the ultrastructure of the nuclei of hairy 
cells did not resemble that of progenitor cells or blasts. 
The B-ly7 antibody recognizes an antigen present on 
the surface of almost all hairy cells; it has recently been 
enclosed in the CD103 cluster (Cepek et al., 1995). 
The expression of this antigen as demonstrated by immu-
nolabeling with 5 nm colloidal gold markers was rela-
tively intense, unquestionably above non-specific back-
ground. Admittedly, counting gold markers present on 
cell surfaces is of limited biological value (de Harven et 
al., 1987). Nevertheless, 100-200 gold markers were 
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frequently counted on one thin-section of a single cell, 
sometime as single markers or as small clusters (Fig. 2). 
It is important to note that a few cells with the typical 
morphology of hairy cells were clearly unlabeled and 
therefore considered as B-ly7 negative. The percentage 
of hairy cells varied considerably from one patient to 
another. The non-hairy cells were mostly lymphocytes. 
Typical monocytes were practically never observed in 
the peripheral blood of these patients, confirming a 
previous report by Seshardi et al. (1976). An extensive 
TEM search for B-ly7 positivity in non-hairy cells of 
these two patients remained entirely negative. In one 
control TEM experiment with mononuclear cells from a 
normal donor, rare lymphocytes were found B-ly7 posi-
tive and all monocytes were found negative. 
Under the SEM, the florid surface morphology of 
hairy cells is striking (Fig. 3). The abundance of ruffles 
and long surface projections is diagnostic at first glance. 
The clinical importance of this observation has long been 
noticed (de Harven and Lampen, 1978). Since the time 
interval between collection of the patient's blood and 
SEM observation can be as short as three to four hours, 
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Figure 4. In the backscattered electron imaging mode (reverse polarity), the 30 nm gold markers are unambiguously 
identified throughout the cell surface of the same hairy cell as that shown on Figure 3. 
reports can reach the clinical hematologists prior to 
therapeutic decisions. Of course, processing time is 
longer if immunogold labeling is performed. Using the 
B-ly7 antibody, most hairy cells were heavily labeled 
(Fig. 4) in spite of the low labeling efficiency of 30 nm 
gold markers (de Harven and Soligo, 1989). According 
to earlier reports (de Harven et al., 1984), and once 
more confirmed here, the backscattered electron (BE) 
imaging mode of the SEM is , by far, the most efficient 
approach to an unambiguous recognition of positively 
labeled cell surfaces. Unquestionably, the search for 
weakly labeled non-hairy cells would have been very dif-
ficult if this investigation had been limited to the use of 
the secondary electron (SE) imaging mode. Using the 
BE mode, one can clearly state that a few hairy cells 
with the typical florid surface morphology were entirely 
B-ly7 negative, as already seen in TEM. At variance 
with the TEM observations, rare B-ly7 positive cells 
with the surface morphology of lymphocytes were ob-
served. This subset of B-ly7 positive cells, obviously 
lymphocytes (de Harven et al., 1986), represented about 
1 % of the total lymphocyte population in this sample. 
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However, an extensive search, in the BE imaging mode, 
for B-ly7 positive lymphocytes in one control sample 
from a normal donor remained entirely negative (230 
cells counted). 
Megakaryoblastic leukemias (M7) 
The study of megakaryoblastic disease has been per-
formed by immuno-TEM, all cells being primed with the 
anti-GpIIIa (CD61) monoclonal antibody . GplIIa, a sur-
face glycoprotein known as one portion of the Gpllb/llla 
complex, was found expressed on all platelets, all mega-
karyocytes and many megakaryoblasts. Seven cases in 
which the diagnosis of M7 was suspected by light mi-
croscopy of peripheral blood films, have been studied 
and the observations summarized as follows. 
All platelets were heavily labeled and served as a 
convenient internal control, ensuring that the Gpllla gly-
coprotein had been effectively labeled with the immuno-
gold marker in each sample. The labeling density, ex-
pressed as the number of 5 nm colloidal gold markers 
per 1 µ,m of cell contour ( de Harven and Christensen, 
1992), was apparently maximum on platelets and served 
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Figure 5. High magnification of a megakaryocyte precursor cell showing intense labeling for the CD61 antigen. Note 
the higher labeling density on the surface of the adjacent platelet (upper right) . 
as a reference to evaluate the level of Gpllla glyco-
protein expression on the surface of megakaryocyte pre-
cursors. Giant platelets, equally heavily labeled, were 
frequently observed. They were somewhat difficult to 
distinguish from circulating megakaryocytes, since the 
apparent absence of any nuclei could be due to thin-
sectioning artifacts. 
Megakaryocyte precursors were identified by the 
presence of either one or more ultrastructural features , 
i.e., (1) alpha granules, (2) demarcation membranes, 
and (3) large surface blebs. More primitive cells of that 
lineage featured a high nucleo/cytoplasmic ratio and a 
predominantly euchromatic nucleus with a large nu-
cleolus. All megakaryocyte precursor cells were found 
CD61 positive (Fig. 5), with various degrees of labeling 
density. A quantitative analysis was performed in an at-
tempt to establish whether or not the cytoplasmic level 
of differentiation correlated with the level of expression 
of the glycoprotein on the cell surface. The results of 
this analysis were completely negative, indicating that 
the presence and/or the number of cytoplasmic differen-
tiation organelles appears independent from the level of 
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expression of Gpllla on cell surfaces, as previously re-
ported (de Harven and Christensen, 1992), although 
platelets and megakaryocytes were always heavily 
labeled. 
Primitive blasts with a very high N/C ratio and 
practically no evidence of cytoplasmic differentiation 
were frequently GpIIIa positive (Fig. 6). The gold 
markers on these cells were evenly distributed along the 
whole contour of these cells and, therefore, do not cor-
respond to focal absorption of platelet membrane frag-
ments as demonstrated by Breton-Gorius et al. (1987) on 
the surface of monocytes. These cells would not have 
been identified as primitive megakaryoblasts without im-
munolabeling for GpIIla. Moreover, since the Illa por-
tion of the glycoprotein complex is expressed early in 
megakaryocytic differentiation (Koller et al. , 1991), we 
probably would have missed identifying these cells had 
we used an antibody directed against the entire complex 
(CD41 and CD61). 
Finally, primitive blasts, very similar to the one 
shown in Figure 6, were found unlabeled. One can only 
hypothesize that some of these cells probably represent 
lmmunogold labeling for the diagnosis of leukemias 
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Figure 6. A primitive megakaryoblast shows weak CD61 labeling (only 9 gold markers can be counted over the entire 
cell margin on this figure , a labeling density which is, however, definitely regarded as above non-specific background). 
Note the large size of the nucleolus, the predominantly euchromatic nucleus, and the high nucleo-cytoplasmic ratio . 
primitive megakaryoblasts. Methods for double irnmu-
nolabeling (de Harven et al., 1990) will be used in fur-
ther studies to find out whether such cells are CD34 
positive and to precisely characterize the ultrastructural 
correlations between the (CD34 + /CD61-) and the 
(CD34+/CD61 +) and (CD34-/CD61 +) phenotypicdif-
ferentiation steps. 
Discussion 
Hairy cell leukemia remains an intriguing disease 
for several reasons. The normal counterpart of hairy 
cells have not, to our knowledge, been identified ultra-
structurally. Hairy cells have never been seen under-
going mitotic division and do not incorporate tritiated 
thymidine (Gee T, personal communication, 1992). 
They share surface features (Polliack et al., 1974) and 
surface markers (Soligo et al., 1985; de Harven et al., 
1992) of lymphocytes and monocytes, and respond well 
to several therapeutic protocols which are without bene-
fit in other forms of leukemia. After the characteriza-
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tion of the B-ly7 monoclonal antibody (Poppema et al., 
1989), one would have expected ultrastructural identifi-
cation of the normal counterpart of hairy cells; yet, to 
our knowledge, this has not so far been reported. Our 
observation ofB-ly7 positive lymphocytes in one case of 
HCL is intriguing because, in one sample from a normal 
donor, we did find B-ly7 positive lymphocytes by TEM 
and could never confirm the finding by SEM. This ap-
parent discrepancy between TEM and SEM observations 
is probably due to the small number of B-ly7 positive 
lymphocytes. Of course, these studies should be repeat-
ed on larger numbers of normal control samples for 
more precise ultrastructural characterization of cells 
which are likely to represent the normal counterparts of 
hairy cells. Further studies with double labeling for 
B-ly7 and B- or T-lymphocyte surface markers will help 
to identify the nature of the B-ly7 positive lymphocytes. 
Still, if such studies do confirm a lymphocytic derivation 
of hairy cells as frequently claimed in the past, we 
would still have to understand why HCLs do not respond 
to therapeutic protocols that induce renuss10ns in 
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lymphoid malignancies. 
From the point of view of the ultrastructural hema-
tologist, hairy cells are interesting for two reasons: (1) 
their surface morphology is the best target for rapid di-
agnostic identification under the SEM, and (2) they fre-
quently feature cytoplasmic ribosome-lamellae com-
plexes (RLC). Admittedly\ RLC have been described in 
non-HCL hematological disorders (see, Ghadially, 1982, 
for a review). However, over the past ten years one of 
us (de Harven) has been studying, with the TEM, more 
than 500 cases of leukemias and associated disorders 
without having ever encountered RLC in non-hairy cell 
diseases. This negative report is probably of some con-
sequence in view of the long standing research interest 
in HCL of this investigator. 
Other remarks concern our GpIIla labeling studies 
on megakaryoblastic leukemia (M7). The seven patients 
studied had advanced, rapidly progressing disease and 
represented a heterogeneous group in which three were 
described as chronic myelogenous leukemia (CML) in 
blast crisis. Could we confirm, by GpIIla labeling of 
PBLs, the existence of a true. megakaryoblastic leukemia 
in all cases? The answers are mostly negative, because 
we frequently observed a spectrum of differentiation of 
megakaryocytic elements which corresponds likely to 
some form of extra-medullary megakaryocytopoiesis or 
megakaryocythemia in patients with bone marrow exten-
sively invaded by another neoplastic clone. 
The presence of megakaryocytes in the peripheral 
blood of normal individuals has long been reported 
(Efrati and Rozenszajn, 1960; Herbeuval et al., 1962a). 
Furthermore, large numbers of megakaryocytes were 
found in the peripheral blood in cases of hematopoietic 
malignancies, particularly in chronic myelogenous leuke-
mia (CML) as reported by Herbeuval et al. (1962b) us-
ing immuno-fluorescence with platelet anti-serum 
(Duheille et al., 1962). These observations confirmed 
an earlier report by Minot (1922) who had already ob-
served that, in some cases of myelogenous leukemia, 
many megakaryocytes appear in the peripheral blood. 
Circulating megakaryocyte progenitors (CFU-MK) were 
described in 9 out of 10 cases of myelofibrosis (Han et 
al., 1988). Moreover, circulating megakaryoblasts were 
characterized by immuno-electron microscopy in ten 
cases of myeloproliferative diseases (Matolcsy and 
Majdic, 1990). 
The identification of megakaryocytes and their pre-
cursors was a matter of great interest in the 1960's when 
many investigators applied the newly discovered methods 
of diagnostic cytology in attempts to demonstrate metas-
tasizing cells in the peripheral blood of cancer patients. 
Hume et al. (1964), for example, using Millipore filtra-
tion and Papanicolaou staining, failed to demonstrate 
embolic tumor cells but recognized the number of mega-
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karyocytes frequently encountered in the peripheral 
blood of patients with a large spectrum of malignant dis-
eases. Identifying circulating megakaryocytes was facili-
tated to an important degree by the demonstration of a 
distinct peroxidase activity (platelet peroxidase, PPO) in 
platelets and megakaryocytes (Breton-Gorius et al., 
1972, 1984). 
In addition, we found no correlation between the 
level of expression of the surface glycoprotein Gpllla 
and ultrastructural markers of differentiation such as 
alpha granules, demarcation membranes and surface 
blebs. However, because of the sensitivity and specifi-
city of GpIIla labeling we were able to recognize early 
megakaryocyte progenitor circulating cells. These cells 
appeared much less differentiated than the PPO positive 
MK precursors described by Breton-Gorius and Vain-
chenker (1986). They are, however, extremely similar 
to the "lymphocyte-like" mononuclear GpIIla positive 
cells demonstrated by Matolcsy and Majdic (1990). 
Further studies will include double labeling for CD34 
and GpIIIa to recognize the early steps in the commit-
ment of primitive blasts to the megakaryocytic lineage. 
Hopefully, double immunogold labeling using anti-
GpIIla lgG and biotinylated anti-CD34 monoclonal anti-
body will soon enable us to analyze the ultrastructure of 
primitive cells during the process of loosing CD34 ex-
pression and acquiring that of GpIIla. This critical step 
in the commitment to megakaryocytic differentiation, 
modulated by the synergistic effect of several growth 
factors, is under active investigation in other laboratories 
(Debili et al., 1993). 
In conclusion, two different forms of leukemia in 
adult patients, i.e., hairy cell leukemia (HCL) and mega-
karyocytic leukemia (M7) have been studied by immuno-
electron microscopy of peripheral blood leukocytes. In 
HCL, electron microscopy provided an important diag-
nostic confirmation, necessary in view of the very spe-
cific response of this disease to certain therapeutic 
protocols. 
In so called "M7'', electron microscopy of PBLs 
demonstrated, in several cases, a spectrum of differentia-
tion probably similar to the megakaryocythemia de-
scribed many years ago by several authors studying the 
peripheral blood of patients with a variety of malignant 
conditions, including CML. Therefore, some of these 
cases should probably not be diagnosed as "megakaryo-
blastic" leukemia (M7). Similarly, when the bone mar-
row is packed with proliferating lymphoblasts, observing 
circulating myelocytes or erythroblasts is never inter-
preted as a need to modify the diagnosis nor to consider 
a possible biphenotypic disease. The high degree of sen-
sitivity and specificity of immunogold labeling for the 
identification of CD61 on primitive megakaryoblasts 
plays a major role in current studies of in vitro and in 
Immunogold labeling for the diagnosis of leukemias 
vivo megakaryocytic differentiation (Zipursky et al., 
1995). 
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Discussion with Reviewers 
Reviewer I: It would be of interest to document the 
precise subcellular distribution of the B-ly7 antibody on 
the hairy cell surface which could add to the understand-
ing of the function of the corresponding antigen. For 
example, adhesion molecules are often concentrated on 
the tip of microvilli. " 
Authors: We are familiar with the frequent concentra-
tion of many antigens on surface microvilli . However, 
this does not seem to be the case for the antigenic sites 
recognized by the B-ly7 or the anti-GpIIIa antibodies. 
Reviewer I : Could you give more information on the 
patients studied, particularly, the bone marrow and 
blood counts? 
Authors: A paper is in preparation which will be sub-
mitted to a hematology journal and in which additional 
clinical data concerning the "Query M7" patients will be 
provided. More details on the clinical data of the HCL 
patients have already been published (see de Harven et 
al. , 1994). 
Reviewer I : Megak:aryocyte precursors that display a-
granules and demarcation membranes are not any more 
precursors but simply megak:aryocytes. The number of 
cytoplasmic organelles cannot be correlated to cell dif-
ferentiation; more important is the nucleus-cytoplasmic 
ratio, texture of the chromatin, and shape of the nucleus. 
Please comment. 
Authors: We do not agree with the reviewer's remarks 
on terminology: we have seen a-granules and/or demar-
cation membranes in apparently diploid cells with a rela-
tively high nucleo/cytoplasmic ratio and which should 
definitely be classified as megakaryocyte precursors. 
J.E. Beesley: In diagnostic testing, control samples are 
obviously of great importance. Would the authors 
please give details of their positive and negative controls 
for their experiments. 
Authors: We have never found any CD61 + cells in 
any other case of leukemia, not considering platelets, of 
course. 
Immunogold labeling for the diagnosis of leukemias 
J.E. Beesley: Would the authors please give an indica-
tion of the immunolabeling normally expected with 
GPIIIa? 
Authors: We have found a considerable variation in the 
level of GpIIla labeling in MK precursor cells, and we 
could not, therefore, illustrate what should be regarded 
as the "normal" level expected in these cells. 
A. Liepins: Is there a particular reason why the B-ly7 
antibody was selected in these studies instead of HML 1, 
Ber-Act 8 and/or LFG 1? 
Authors: The reason we have worked with the B-ly7 
antibody is simply that it was kindly made available to 
us by Dr. S. Poppema. We would be most interested if 
the reactivity of hairy cells for HML 1, Ber-Act 8 
and/or LFG 1 would receive similar attention in the fu-
ture, in view of the fact that they all belong to the 
CD103 cluster, as recently published (Cepek et al., 
1995). Blocking experiments would be useful in ascer-
taining whether or not these various antibodies compete 
indeed for the same or closely adjacent antigenic sites. 
A. Liepins: In the megakaryoblastic leukaemia (M7) 
cases, labelling was carried out with anti-GPIIIa 
(CD-61) which recognizes fibronectin and vibronectin 
receptors on megakaryocytes and platelets. How do 
these results contribute to the clinical diagnosis of this 
type of leukaemia? 
Authors: Labelling with anti-GPIIIa did not contribute 
significantly to the diagnosis of M7 leukemia primarily 
because, in most of our cases, a broad spectrum of dif-
ferentiation of CD61 + cells were recognized by TEM, 
which is hardly compatible with the identification of leu-
kemic clones. Anti-CD61 labelling made it possible to 
recognize megakaryocyte precursor cells which would 
have been, otherwise, left unidentified. It helped to 
recognize the spectrum of differentiation which frequent-
ly characterizes the megakaryocythemia accompanying 
some cases of CML and other myeloproliferative disor-
ders. But it did not permit to identify these CD61 + 
cells as actually leukemic. In short, our study indicated 
that it is far from enough to recognize megakaryocyte 
precursor cells on blood films by light microscopy to 
consolidate a diagnosis of M7 leukemia and that immu-
nogold-TEM with anti-CD61 can only confirm mega-
karyocythernia, not the megakaryocytic nature of the dis-
ease or of the blast crisis observed in some cases of 
CML. 
R.M. Albrecht: The authors note cells, as the one 
shown in Figure 6, can be found either labeled or un-
labeled. They note at higher magnification 9 gold par-
ticles are seen on the cell. The authors should make 
clear that this is over the entire cell margin, not just the 
1201 
portion seen at higher magnification? It might be useful 
to note what 9 particles in one section relate to, roughly, 
with respect to the total number of labels over the entire 
cell surface, i.e., what would be seen by SEM. What 
is the normal "background"? 
Authors: First, the question of "normal background". 
One of the most significant advantages of immunogold 
labeling is its remarkably low non-specific background, 
as compared, for example, with techniques of immuno-
peroxidase. Still in all our immunogold labeling work, 
we had to set a threshold of significance. We have al-
ways set this, arbitrarily, at 5 gold particles (5 nm) for 
the entire cell contour. In the case illustrated in Figure 
6, we counted 9 gold markers on the entire cell contour 
and, therefore, regarded that cell as B-ly7 positive. We 
wish we could be more explicit in terms of these num-
bers counted with EM as they equate to the entire cell 
surface as seen by SEM. Simple extrapolations are im-
possible, mainly because we used 5 nm gold for TEM 
and 30 nm gold for SEM, these two markers having, as 
is well-known, very different labeling efficiency. 

